QM · rank #15 · 2026-10-27
SNT
GPW · PLN · $726M (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +44.65% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +217.6% |
| Profit margin Net profit margin, trailing 12 months. | +44.8% |
| Market cap (USD) Size filter: > $300M required (USD-equivalent). | $726M |
| Anchor (recent) Close on 2026-09-25 | $353.00 |
| Anchor (far) Close on 2025-09-26 | $244.03 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Synektik S.A. is the exclusive CEE and Baltic distributor and service provider for Intuitive Surgical’s da Vinci robotic-surgery systems, medical imaging equipment, and radiopharmaceuticals.
Rationale
High return on equity and 44.8% profit margins alongside 52% year-over-year revenue growth validate the quality-momentum signal as da Vinci system adoption expands across Central European healthcare providers.
Material risks
- 1Strategic dependence on Intuitive Surgical's exclusive distribution agreement through 2031, leaving the business exposed to future contract non-renewal or technological displacement by competing robotic surgery platforms.
- 2Vulnerability to public healthcare capital expenditure cycles and tender execution delays, as evidenced by the order backlog contracting to PLN 43.3 million at September 30, 2026.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.